
VistaGen Therapeutics (VTGN) Earnings Dates & Reports
VistaGen Therapeutics (VTGN) Most Recent Earnings
Report DateAug 7, 2025
Period EndingQ1 2026
Est. EPS-$0.45
Actual EPS-$0.47
EarningsMiss
VistaGen Therapeutics (VTGN) Earnings
View the latest VistaGen Therapeutics (VTGN) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in VistaGen Therapeutics (VTGN)
Order type
Buy in
Order amount
Est. shares
0 shares
VistaGen Therapeutics (VTGN) Earnings per Share (EPS) History
Signup for full accessBrowse free
VistaGen Therapeutics (VTGN) Latest Earnings
The value each VTGN share was expected to gain vs. the value each share gained.
VistaGen Therapeutics (VTGN) reported its most recent earnings on Aug 7, 2025 for Q1 2026, posting earnings per share (EPS) of -$0.47. This exceeded analysts' expectations of -$0.45 by 4.44%, marking a Miss.
For comparison, VistaGen Therapeutics reported EPS of -$0.35 in the same quarter last year.
The company is expected to announce its next earnings report on 11/06/2025, with analysts projecting an EPS of -$0.46.
VistaGen Therapeutics (VTGN) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2026Nov 6, 2025 | -$0.46 | Next earnings call Nov. 6, 2025 | ||
Q1 2026Aug 7, 2025 | -$0.45 | -$0.47 | +4.44% | |
Q4 2025Jun 17, 2025 | -$0.49 | -$0.44 | -10.20% | |
Q3 2025Feb 13, 2025 | -$0.52 | -$0.46 | -11.54% | |
Q2 2025Nov 7, 2024 | -$0.39 | -$0.42 | +7.69% | |
VistaGen Therapeutics (VTGN) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the VistaGen Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 7, 2025 | — | — | — |
Jun 17, 2025 | — | — | — |
Feb 13, 2025 | — | — | — |
Nov 7, 2024 | — | — | — |
VistaGen Therapeutics (VTGN) Earnings FAQs
VistaGen Therapeutics (VTGN) last reported earnings on Aug 7, 2025 for Q1 2026, posting an EPS of -$0.47, which Miss the estimate of -$0.45 by 4.44%.
For Q1 2026, VistaGen Therapeutics (VTGN) reported an EPS of -$0.47, missing analysts' estimate of -$0.45 by 4.44%.
For Q1 2026, VistaGen Therapeutics (VTGN) Miss expectations with an actual EPS of -$0.47 vs. an estimated EPS of -$0.45.
Following the last earnings report on Aug 7, 2025, VistaGen Therapeutics (VTGN)'s stock price moved — from — to —.
The next VistaGen Therapeutics (VTGN) earnings call is scheduled for Nov. 6, 2025, where executives will discuss financial results and outlook.